David Bennett to Glucosylceramidase
This is a "connection" page, showing publications David Bennett has written about Glucosylceramidase.
Connection Strength
0.159
-
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology. 2012 Nov 06; 79(19):1944-50.
Score: 0.110
-
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet. 2021 03; 53(3):294-303.
Score: 0.049